ArticleAnnals of medicine and surgery (2012)2026
Transoral endoscopic thyroidectomy vestibular approach versus open thyroidectomy in surgical resection of the thyroid: a systematic review and meta-analysis.
Article in Annals of medicine and surgery (2012), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The increasing incidence of thyroid nodules and thyroid cancer, particularly among women, has driven the evolution of minimally invasive thyroidectomy techniques. The transoral endoscopic thyroidectomy vestibular approach (TOETVA) has emerged as a promising alternative to conventional open thyroidectomy (OT). This study aimed to compare operative time, blood loss, drainage volume, lymph node yield, and postoperative complications between TOETVA and OT. Methods: A comprehensive search was conducted across PubMed, Embase, ClinicalTrials.gov, and Web of Science. Randomized controlled trials, cohort studies, and retrospective studies comparing TOETVA and OT were included. Statistical analysis was performed using RevMan version 5.3. Standardized mean differences and odds ratios with 95% confidence intervals were calculated. A Results: A total of 22 studies involving 4397 patients were included. TOETVA was associated with a significantly longer operative time and higher drainage volume. However, no significant differences were observed in blood loss, number of retrieved central lymph nodes, metastatic lymph node yield, recurrent laryngeal nerve palsy, seroma formation, or wound infection. Conclusion: TOETVA represents a safe and feasible alternative to OT, offering comparable surgical and oncological outcomes with the added benefit of superior cosmetic results.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.